Sign in

Trial result ·

Ultrasound-Guided Stellate Ganglion Block in Fibromyalgia: A Randomized, Single-Center, Single-Blind, Sham-Controlled Trial.

Written based on 1 research study on PubMed, searched on 13 Nov 2026.

What was studied

This study tested a nerve block for fibromyalgia pain. The block is aimed at the stellate ganglion. Doctors used ultrasound to guide it. All the adults already took duloxetine 60 mg each day. Their symptoms had not eased enough with drugs. People were split by chance into a real block group or a fake procedure group. The trial was single-blind, but the abstract does not say who was blinded. Each person had a second procedure 1 week after the first.

What they found

Of 108 people screened, 68 joined the trial. In all, 60 people finished every test, 30 in each group. A form scored the impact of fibromyalgia. These scores fell more with the real block. At 1 week, the gap was 29.9 points in favor of the block. At 1 month, the gap was 22.9 points. Pain scores also dropped more with the block. The gap was 3.1 points at 1 week. It was 2.6 points at 1 month. No serious problems happened. Side effects were mild and did not last.

What it means for patients

The authors say the block gave short-term gains in pain that matter. It also lowered the impact of fibromyalgia. They judged its safety to be acceptable. These results were in people already on duloxetine who still had symptoms.

Why it is not certain yet

The authors warn the large effects should be read with care. People may have guessed which group they were in. Placebo effects may also explain part of the gain. The trial was run at a single center. Follow-up lasted only 1 month. The authors call for larger trials with longer follow-up and firmer measures.

The registered trial

The paper names this trial from a public trial registry. Its page shows who the trial is for, its sites and its status.

Source

Ultrasound-Guided Stellate Ganglion Block in Fibromyalgia: A Randomized, Single-Center, Single-Blind, Sham-Controlled Trial.

PubMed · PMID 42530408

We restate facts from the source record in our own words. The original wording belongs to its publisher.

This page is not medical advice. Talk to your doctor about your own care.

Back to Fibromyalgia publications